Perspectives in Breast Cancer Pathology

by Michael Lagios, MD

     

 

       Please click on title to view complete text:

 

Contradictory Treatment Recommendations for Ductal Carcinoma in situ (DCIS).

​

Risk of DCIS Recurrence by Oncotype DCIS Technology - Some Concerns.

​

The Clinical Significance of immunohistochemically Detectable Epithelial Cells in Sentinel Lymph Node and Bone Marrow in Breast Cancer.

​

Factors Influencing the Accuracy of a Core Biopsy Diagnosis of Atypical Hyperplasia.  A Perspective on a Frequent Pattern.

​

Tamoxifen as an Adjuvant Agent for Ductal Carcinoma In Situ (DCIS)